The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
A first-in-human phase 1 dose-escalating trial of G305 in patients with solid tumors expressing NY-ESO-1.
 
Amit Mahipal
No Relationships to Disclose
 
Kunle Odunsi
No Relationships to Disclose
 
Sacha Gnjatic
Consulting or Advisory Role - Boehringer Ingelheim; Third Rock Ventures
Research Funding - Immune Design (Inst); Janssen Research & Development (Inst)
Patents, Royalties, Other Intellectual Property - Ludwig Institute for Cancer Research
Travel, Accommodations, Expenses - Boehringer Ingelheim; Third Rock Ventures
 
Seunghee Kim-Schulze
No Relationships to Disclose
 
Richard T. Kenney
Employment - Crucell; Immune Design
Leadership - Immune Design
Stock and Other Ownership Interests - Immune Design
 
Samuel Ejadi
No Relationships to Disclose